Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Zehetner

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
BMJ Open|December 22, 2021
Efficiency benchmarks in the surgical management of primary rhegmatogenous retinal detachment: a monocentric register cohort study of operating room time metrics and influential factorsReinhard Angermann, Anna Lena Huber, Markus Hofer, et al.
Investigative Ophthalmology & Visual Science|December 17, 2013
Systemic upregulation of PDGF-B in patients with neovascular AMDClaus Zehetner, Rudolf Kirchmair, Sabrina B Neururer, et al.
Investigative Ophthalmology & Visual Science|May 30, 2015
Systemic counterregulatory response of placental growth factor levels to intravitreal aflibercept therapyClaus Zehetner, Nikolaos E Bechrakis, Martin Stattin, et al.
Clinical & Experimental Ophthalmology|April 17, 2021
Impact of submacular fluid volume on visual outcome in macula-off rhegmatogenous retinal detachment using automated optical coherence tomography volumetric quantificationReinhard Angermann, Stefan Mosböck, Christoph Palme, et al.
Acta Ophthalmologica|June 19, 2021
The impact of compliance among patients with diabetic macular oedema treated with intravitreal aflibercept: a 48-month follow-up studyReinhard Angermann, Markus Hofer, Anna Lena Huber, et al.
Retina (Philadelphia, Pa.)|October 6, 2022
OPTICAL COHERENCE TOMOGRAPHY AND OCT ANGIOGRAPHY CHARACTERISTICS OF INDOCYANINE GREEN ANGIOGRAPHIC PLAQUES IN NONEXUDATIVE AGE-RELATED MACULAR DEGENERATIONMartin Stattin, Daniel Ahmed, Anna-Maria Haas, et al.
Klinische Monatsblatter Fur Augenheilkunde|April 21, 2022
The Impact of the COVID-19 Pandemic on the Quality of Care of Treatment-Naïve Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal AfliberceptReinhard Angermann, Alexander Franchi, Katharina Frede, et al.
Retina (Philadelphia, Pa.)|November 3, 2021
CHANGES IN SYSTEMIC LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL INJECTION OF AFLIBERCEPT OR BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONReinhard Angermann, Anna Lena Huber, Yvonne Nowosielski, et al.
Acta Ophthalmologica|December 16, 2020
Systemic counterregulatory response of angiopoietin-2 after aflibercept therapy for nAMD: a potential escape mechanismReinhard Angermann, Teresa Rauchegger, Yvonne Nowosielski, et al.
Acta Ophthalmologica|June 3, 2021
Bilateral cataract surgery improves neurologic brake reaction time and stopping distance in elderly driversYvonne Nowosielski, Benedikt Leitner, Teresa Rauchegger, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
BMJ Open|December 22, 2021
Efficiency benchmarks in the surgical management of primary rhegmatogenous retinal detachment: a monocentric register cohort study of operating room time metrics and influential factorsReinhard Angermann, Anna Lena Huber, Markus Hofer, et al.
Investigative Ophthalmology & Visual Science|December 17, 2013
Systemic upregulation of PDGF-B in patients with neovascular AMDClaus Zehetner, Rudolf Kirchmair, Sabrina B Neururer, et al.
Investigative Ophthalmology & Visual Science|May 30, 2015
Systemic counterregulatory response of placental growth factor levels to intravitreal aflibercept therapyClaus Zehetner, Nikolaos E Bechrakis, Martin Stattin, et al.
Clinical & Experimental Ophthalmology|April 17, 2021
Impact of submacular fluid volume on visual outcome in macula-off rhegmatogenous retinal detachment using automated optical coherence tomography volumetric quantificationReinhard Angermann, Stefan Mosböck, Christoph Palme, et al.
Acta Ophthalmologica|June 19, 2021
The impact of compliance among patients with diabetic macular oedema treated with intravitreal aflibercept: a 48-month follow-up studyReinhard Angermann, Markus Hofer, Anna Lena Huber, et al.
Retina (Philadelphia, Pa.)|October 6, 2022
OPTICAL COHERENCE TOMOGRAPHY AND OCT ANGIOGRAPHY CHARACTERISTICS OF INDOCYANINE GREEN ANGIOGRAPHIC PLAQUES IN NONEXUDATIVE AGE-RELATED MACULAR DEGENERATIONMartin Stattin, Daniel Ahmed, Anna-Maria Haas, et al.
Klinische Monatsblatter Fur Augenheilkunde|April 21, 2022
The Impact of the COVID-19 Pandemic on the Quality of Care of Treatment-Naïve Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal AfliberceptReinhard Angermann, Alexander Franchi, Katharina Frede, et al.
Retina (Philadelphia, Pa.)|November 3, 2021
CHANGES IN SYSTEMIC LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL INJECTION OF AFLIBERCEPT OR BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONReinhard Angermann, Anna Lena Huber, Yvonne Nowosielski, et al.
Acta Ophthalmologica|December 16, 2020
Systemic counterregulatory response of angiopoietin-2 after aflibercept therapy for nAMD: a potential escape mechanismReinhard Angermann, Teresa Rauchegger, Yvonne Nowosielski, et al.
Acta Ophthalmologica|June 3, 2021
Bilateral cataract surgery improves neurologic brake reaction time and stopping distance in elderly driversYvonne Nowosielski, Benedikt Leitner, Teresa Rauchegger, et al.
Pageof 5